0

Journal Articles

in Heart Failure
 21-40 of 369 Articles
JAMA | 
Editorial |  November 28, 2012
Heart Failure Therapy:  What Should Clinicians Believe?
James C. Fang, MD
JAMA. 2012;308(20):2144-2146. doi:10.1001/jama.2012.45418.
JAMA | 
Original Contribution |  November 28, 2012 FREE
Association Between Use of Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure and Preserved Ejection Fraction
Lars H. Lund, MD, PhD; Lina Benson, MSc; Ulf Dahlström, MD, PhD; et al.
JAMA. 2012;308(20):2108-2117. doi:10.1001/jama.2012.14785.
INCLUDES: , Supplemental Content
JAMA | 
Original Contribution |  November 28, 2012 FREE
Associations Between Aldosterone Antagonist Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Reduced Ejection Fraction
Adrian F. Hernandez, MD, MHS; Xiaojuan Mi, PhD; Bradley G. Hammill, MS; et al.
JAMA. 2012;308(20):2097-2107. doi:10.1001/jama.2012.14795.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Original Investigation |  October 08, 2012
The Causes, Treatment, and Outcome of Acute Heart Failure in 1006 Africans From 9 Countries:  Results of the Sub-Saharan Africa Survey of Heart Failure
Albertino Damasceno, MD, PhD; Bongani M. Mayosi, DPhil, FCP(SA); Mahmoud Sani, MBBS; et al.
Arch Intern Med. 2012;172(18):1386-1394. doi:10.1001/archinternmed.2012.3310.
JAMA Internal Medicine | 
Invited Commentary |  October 08, 2012
Hypertension as an Emerging Risk Factor for Acute Heart Failure in Africa:  Comment on “The Causes, Treatment, and Outcome of Acute Heart Failure in 1006 Africans From 9 Countries”
Kenneth A. Jamerson, MD; Lawrence Agodoa, MD
Arch Intern Med. 2012;172(18):1395-1396. doi:10.1001/archinternmed.2012.4491.
JAMA Internal Medicine | 
Research Letters |  September 10, 2012
Improved Outcomes in Heart Failure Treated With High-Dose ACE Inhibitors and ARBs: A Population-Based Study
Giordano Egiziano, BSc; Louise Pilote, MD, PhD, MPH; Hassan Behlouli, PhD; et al.
Arch Intern Med. 2012;172(16):1263-1265. doi:10.1001/archinternmed.2012.2514.
JAMA | 
Original Contribution |  August 01, 2012 FREE
Effects of Exercise Training on Depressive Symptoms in Patients With Chronic Heart Failure:  The HF-ACTION Randomized Trial
James A. Blumenthal, PhD; Michael A. Babyak, PhD; Christopher O’Connor, MD; et al.
JAMA. 2012;308(5):465-474. doi:10.1001/jama.2012.8720.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Research Letters |  May 14, 2012 FREE
The Increasing Burden of Atrial Fibrillation Compared With Heart Failure and Myocardial Infarction: A 15-Year Study of All Hospitalizations in Australia
Christopher X. Wong, MBBS; Anthony G. Brooks, PhD; Darryl P. Leong, MBBS, MPH, PhD; et al.
Arch Intern Med. 2012;172(9):739-741. doi:10.1001/archinternmed.2012.878.
JAMA Internal Medicine | 
Research Letters |  May 14, 2012 FREE
Invited Commentary—Global Arrhythmia Burden: The Public Health Implications of the Rise in Atrial Fibrillation
Comment on “The Increasing Burden of Atrial Fibrillation Compared With Heart Failure and Myocardial Infarction”
Rajat Deo, MD, MTR; Paul D. Varosy, MD
Arch Intern Med. 2012;172(9):741-742. doi:10.1001/archinternmed.2012.1294.
JAMA | 
Original Contribution |  April 25, 2012 FREE
Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart Failure:  The FOCUS-CCTRN Trial
Emerson C. Perin, MD, PhD; James T. Willerson, MD; Carl J. Pepine, MD; et al.
JAMA. 2012;307(16):1717-1726. doi:10.1001/jama.2012.418.
JAMA | 
Original Contribution |  April 11, 2012 FREE
Association of Treatment With Losartan vs Candesartan and Mortality Among Patients With Heart Failure
Henrik Svanström, MSc; Björn Pasternak, MD, PhD; Anders Hviid, MSc, Dr Med Sci
JAMA. 2012;307(14):1506-1512. doi:10.1001/jama.2012.452.
JAMA | 
Viewpoint |  March 21, 2012
Evaluating Sex Differences in Medical Device Clinical Trials:  Time for Action
Sanket S. Dhruva, MD; Rita F. Redberg, MD, MSc
JAMA. 2012;307(11):1145-1146. doi:10.1001/jama.2012.254.
JAMA | 
Original Contribution |  March 14, 2012 FREE
Association of Hospital Spending Intensity With Mortality and Readmission Rates in Ontario Hospitals
Therese A. Stukel, PhD; Elliott S. Fisher, MD, MPH; David A. Alter, MD, PhD; et al.
JAMA. 2012;307(10):1037-1045. doi:10.1001/jama.2012.265.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Research Letters |  February 13, 2012 FREE
Enjoying Life and Living Longer
Andrew Steptoe, DSc; Jane Wardle, PhD
Arch Intern Med. 2012;172(3):273-275. doi:10.1001/archinternmed.2011.1028.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Editor's Correspondence |  January 09, 2012
The Transitionalist: Optimizing Inpatient-to-Outpatient Transitions of Care
Ken S. Ota, DO
Arch Intern Med. 2012;172(1):81-82. doi:10.1001/archinternmed.2011.611.
JAMA Internal Medicine | 
Original Investigation |  November 28, 2011 FREE
Secondhand Smoke Exposure and Quality of Life in Patients With Heart Failure
Sarah G. Weeks, MD; Stanton A. Glantz, PhD; Teresa De Marco, MD; et al.
Arch Intern Med. 2011;171(21):1887-1893. doi:10.1001/archinternmed.2011.518.
JAMA | 
Original Contribution |  November 23, 2011 FREE
Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart Failure
Todd Kiefer, MD, PhD; Lawrence Park, PhD; Christophe Tribouilloy, MD, PhD; et al.
JAMA. 2011;306(20):2239-2247. doi:10.1001/jama.2011.1701.
INCLUDES: , Supplemental Content
JAMA | 
JAMA Patient Page |  November 16, 2011 FREE
Heart Failure
Janet M. Torpy, MD; Cassio Lynm, MA; Robert M. Golub, MD
JAMA. 2011;306(19):2175. doi:10.1001/jama.306.19.2175.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Editor's Correspondence |  October 24, 2011
Risk of Heart Failure With Human Immunodeficiency Virus Is Greater Than Hypertension?
Alexandre José de Melo Neto; Francisca Mosele; Sandra C. Fuchs, MD, PhD
Arch Intern Med. 2011;171(19):1773-1774. doi:10.1001/archinternmed.2011.490.
JAMA Internal Medicine | 
Editor's Correspondence |  October 24, 2011
Risk of Heart Failure With Human Immunodeficiency Virus Is Greater Than Hypertension?—Reply
Adeel A. Butt, MD, MS; Amy C. Justice, MD, PhD; Matthew S. Freiberg, MD, MSc
Arch Intern Med. 2011;171(19):1773-1774. doi:10.1001/archinternmed.2011.560.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  April 22, 2013
Nullius In Verba:  Don't Take Anyone's Word for It
Richard S. Lehman, MA, BM,  BCh, MRCGP
JAMA
Viewpoint  |  March 28, 2013
Strategies and Opportunities for Drug Development in Heart Failure
Javed Butler, MD, MPH; Gregg C. Fonarow, MD; Mihai Gheorghiade, MD
JAMA
Research Letters  |  April 17, 2013
Long-term Outcomes of Left Anterior Fascicular Block in the Absence of Overt Cardiovascular Disease
Mala C. Mandyam, BS; Elsayed Z. Soliman, MD; Susan R. Heckbert, MD, PhD; et al.
JAMA
Preliminary Communication  |  April 17, 2013
Effect of Shock Wave–Facilitated Intracoronary Cell Therapy on LVEF in Patients With Chronic Heart Failure:  The CELLWAVE Randomized Clinical Trial
Birgit Assmus, MD; Dirk H. Walter, MD; Florian H. Seeger, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems